Do the claim limits for High-Cost Drugs (HCD) and Cell, Tissue and Gene Therapy Products (CTGTP) apply if these treatments are administered during an inpatient stay or day surgery?
Yes, if a patient receives High-Cost Drugs (HCD) or Cell, Tissue and Gene Therapy Products (CTGTP) treatment during an inpatient or day surgery admission, the respective HCD/CTGTP claim limit will apply to these treatments, while the daily inpatient hospital limit will apply to the room and board charges. This ensures adequate healthcare financing support by MediShield Life and MediSave for patients who receive HCD or CTGTP treatment in inpatient or day surgery settings.
This information is sourced from CPF
Related questions
Why is MediShield Life covering treatments such as Cell, Tissue and Gene Therapy Products (CTGTPs) and high-cost drugs which might only benefit a small number of patients?
Does the Cancer Drug List also apply to inpatient cancer drug treatments under MediShield Life and MediSave?
Does the Cancer Drug List also apply to inpatient cancer drug treatments under MediShield Life and MediSave?
Why is MediShield Life covering treatments such as CTGTPs and high-cost drugs that only benefit a small number of patients?
Need more help?
Get in touch